banner
bloodjournals.hematology.org
Blood Journals' Portfolio
@bloodjournals.hematology.org
2K followers 920 following 920 posts
Portfolio of peer-reviewed journals from ASH including Blood, the most cited peer-reviewed publication in hematology, and Blood Advances, Blood Global Hematology, Blood ICT, Blood Neoplasia, Blood RCI, and Blood VTH https://linktr.ee/bloodjournalsportfolio
linktr.ee
Posts Media Videos Starter Packs
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 18h
This press release highlights how patients with sickle cell disease in vaso-occlusive crisis are often under-triaged resulting in poor adherence to pain management guidelines. Read the study in Blood Advances here: ashpublications.org/bloodadvance... #SickleCellDisease #BloodJournals #Hematology
ash.hematology.org
American Society of Hematology @ash.hematology.org · 18h
Patients with sickle cell disease often wait hours for pain relief in the ER when triage doesn’t follow guidelines. Proper Emergency Severity Index (ESI) scoring can dramatically speed access to medication. https://ow.ly/s3aQ50X8xKM

#ConquerSCD #SickleCell #HemeSky
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 1d
✨Explore our portfolio - today featuring Blood Immunology & Cellular Therapy!✨Learn more about the journal's scope, why you should submit, and the editors who are experts in their field: www.linkedin.com/feed/update/...
2
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 2d
Age-based or TDM-guided FLU dosing has the potential to improve CAR T-cell patient outcomes. buff.ly/2TMTQJn #hemesky
2
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 5d
The mTORC2-Foxo1 axis represents a potential therapeutic target for hereditary hemochromatosis. buff.ly/LIHEeCj #hemesky
2
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 5d
Patients with WM and CXCR4 mutations have improved outcomes with I+R vs I. buff.ly/goUOs4v #hemesky
2
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 6d
New Blood issue out featuring:
The acute myeloid leukemia microenvironment impairs neutrophil maturation and function through NF-κB signaling buff.ly/0vhlcDl
3
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 6d
🎙️ Just published a new episode of Blood Podcast: How I Treat Wiskott-Alrich syndrome. Have a listen:
How I Treat Wiskott-Alrich syndrome
In this How I Treat podcast episode, Laura Michaelis, MD interviews...
bloodpodcast.transistor.fm
2
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 6d
🎙️ Just published a new episode of Blood Podcast: Use of Marstacimab for Prophylaxis in hemophilia A and B; matched-donor allogeneic CD19 CAR-T in adult B-ALL; a new prognostic index for T-cell cutaneous lymphomas. Have a listen:
Use of Marstacimab for Prophylaxis in hemophilia A and B; matched-donor allogeneic CD19 CAR-T in adult B-ALL; a new prognostic index for T-cell cutaneous lymphomas
In this week's episode we'll learn about targeting the tissue factor...
bloodpodcast.transistor.fm
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 6d
Patient distance to nearest CAR-T center predicts treatment probability; residents of low-income states had reduced access to CAR-Ts. buff.ly/pxXp43j #hemesky
1
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 7d
Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails buff.ly/xpMvyFs #hemesky
1
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 7d
Maintenance romidepsin is feasible after AHCT. buff.ly/UI6nZS7 #hemesky
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 8d
🌍 September is Sickle Cell Disease Awareness Month and together we are working to #ConquerSCD!
🔊 Ruxolitinib plus dexamethasone in newly diagnosed adult hemophagocytic lymphohistiocytosis 🎧 buff.ly/LyxrSuu #SCD #SCDC
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 8d
The toxicity profile of CAR T cells in relapsed/refractory TriNHL is acceptable. buff.ly/wmybPGD #hemesky
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 8d
Somatic preleukemic GATA1s mutations are acquired before birth in 25% of neonates with DS, and are not acquired postnatally. buff.ly/vKCMYCm #hemesky
1
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 9d
ICYMI: Blood Neoplasia and Blood VTH are now indexed in PubMed! Your research in hematologic malignancies or vascular biology, thrombosis, and hemostasis will now be more discoverable than ever. Submit today: buff.ly/OcEH3eB #PubMed #BloodJournals #Hematology
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 9d
Biallelic disruption of CD38 is a rare but recurrent phenomenon in anti-CD38–exposed relapsed/refractory MM. buff.ly/eCkT4hx #hemesky
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 9d
In DLBCL, BCR was not associated with relapse, whereas in B-ALL, responses were maintained despite late BCR (>6 months). buff.ly/B0lYygB
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 9d
🌍 September is Sickle Cell Disease Awareness Month and together we are working to #ConquerSCD!
🔊 A novel mouse model of sickle cell SC disease 🎧 buff.ly/tyl4Ern #SCD #SCDC
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 10d
Youth with SCD indicated a preference for starting transition education in their midteens, at least twice a year, using various approaches. buff.ly/0kZOoJF #hemesky
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 11d
Voruciclib decreased Mcl-1 protein expression and RNA polymerase II phosphorylation, demonstrating on-target effects. buff.ly/HcJGWXo #hemesky
1
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 12d
Let Us Take a Second Look 👀
With our #secondlook program, researchers can submit manuscripts previously submitted to other reputable journals to the 5 specialized journals in the Blood portfolio for a rapid review. Receive an initial decision in 3 business days: buff.ly/W42QQlu
3
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 12d
Obinutuzumab combined with lenalidomide was well tolerated with the most common AEs being diarrhea, rash, and fatigue. buff.ly/hkxzPlN #hemesky
2
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 13d
Loss of PROSER1 impairs HSC function without compromising TET-mediated leukemia suppression. buff.ly/Jb0YFvl #hemesky
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 13d
New Blood issue out now featuring:
Association of Epstein-Barr virus genomic alterations with human pathologies buff.ly/2elfGXV
1
bloodjournals.hematology.org
Blood Journals' Portfolio @bloodjournals.hematology.org · 13d
🌍 September is Sickle Cell Disease Awareness Month and together we are working to #ConquerSCD!
🔊 Measurable residual disease and maintenance therapy in acute myeloid leukemia, stemness and chemotherapy resistance in AML 🎧 buff.ly/RDIZMuC
1